ACellular Therapies

At Lovinium Biotech, our goal is to positively impact human health and well-being by utilizing innovative technology and market-leading scientists to create new ways for people to live longer, healthier lives. Our mission is to pioneer the most effective methods for improving human health.

Lovinium Biotech has been built on the principles of collaboration, innovation, and excellence. Our vision is to become a global leader in acellular therapy products, human gene therapy products, and certain devices related to cell and gene therapy. Our portfolio includes cellular immunotherapies, cancer vaccines, and other types of both autologous and allogeneic cells for certain therapeutic indications, including hematopoietic stem cells and adult and embryonic stem cells. Lovinium’s global team focuses on research and development projects that deliver superior cures for patients worldwide through novel diagnostic tests as well as next-generation gene therapies.